D. Gras (Marseille, France), O. Holz (Hannover, Germany)
Increased inflammatory response and cytokine release (TNF-alpha, IL-8) after environmental tobacco smoke exposure in patients with asthma
R. E. Mikes, B. Lamprecht, F. Grabcanovic-Musija, G. Weiß, H. Dobias, M. Gaisberger, R. Sanovic, A. Hartl, M. Studnicka (Salzburg, Austria)
|   |
LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results
A. Proklou, E. Neofytou, M. Psarrou, S. Schiza, N. Siafakas, E. Tzortzaki (Heraklion, Greece)
| |
Mechanisms responsible for glucocorticoid insensitivity in nasal mucosa and nasal polyps
L. Fernandez-Bertolin, I. Alobid, J. Mullol, C. Picado, L. Pujols (Barcelona, Spain)
| |
Cox-2 regulation by IL-1β through MAPKs: A comparison of nasal mucosa and nasal polyps fibroblasts from AIA patients
F. J. Garcia-Garcia, J. Roca-Ferrer, M. Pérez, I. Alobid, J. Mullol, C. Picado (Barcelona, Madrid, Spain)
| |
Different profiles of lung and systemic regulatory T cells in mild asthmatics
K. Matsunaga, T. Kawayama, K. Yamaguchi, T. Hoshino, H. Aizawa (Japan)
| |
LSC 2010 Abstract: Experimental asthma: expression and activation of protein kinase C isoenzymes in airway smooth muscles (ASM) & lymphocytes and structural changes in lung tissues during the development of airway hypersensitivity in guinea pig model of asthma
R. K. Mishra, R. Kulshrestha, S. K. Chhabra, S. K Bansal (Delhi, India)
| |
Mechanisms of airway smooth muscle reactivity in an allergen-induced asthmatic reaction in rats
A. Barmina, J. Sehlin, A. Zashikhin (Sweden; Arkhangelsk, Russian Federation)
| |
Airways renin angiotensin system activation during allergic lung disease
I. L. Dumitriu, B. Gurzu, P. Plamadeala, L. Foia (Iasi, Romania)
| |
LSC 2010 Abstract: Creatine supplementation upregulates chronic allergic airway inflammation and remodeling via activation of epithelial cells
R. de Paula Vieira, S. Cesar Ferreira, M. Hage, A. Choqueta Toledo, A. B. G. Santos, M. C. R. Medeiros, M. Arruda Martins, C. R. F. Carvalho, M. Idzko, S. Cicko, M. Dolhnikoff (Sao Paulo, Brazil; Freiburg, Germany)
| |
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers
C. Calabrese, L. Varriale, C. Turino, A. Vatrella, C. Guarino, M. Del Donno, N. Corcione, I. Pedicelli, P. Somma, P. Micheli, S. A. Marsico (Naples, Benevento, Italy)
| |
Heat shock proteins and FKBP51 expression in sputum cells of COPD patients during formoterol/budesonide/theophylline therapy
R. Mroz, A. Holownia, E. Chyczewska, J. Braszko (Poland)
| |
Anti-CP antibodies interact with smoke exposure to influence lung function
A. Wood, P. de Pablo, C. Buckley, R. Stockley (Birmingham, United Kingdom)
| |
Ionomycin stimulates a synergistic effect of IL-8 and induced sputum on PMN chemotaxis during COPD
A. Babusyte, J. Jeroch, K. Stravinskaite, R. Stakauskas, K. Malakauskas, R. Sakalauskas (Lithuania; Hannover, Germany)
| |
Induced sputum, but not BALF stimulated PMN ROS production is enhanced by ionomycin during COPD
A. Babusyte, J. Jeroch, K. Stravinskaite, R. Stakauskas, K. Malakauskas, R. Sakalauskas (Lithuania; Hannover, Germany)
| |
Biomarkers in COPD patients: Relationship with severity indices
F. Costa, L. Malagrinò, C. Silvana, P. Tarlà, C. De Simone, B. Vagaggini, P. L. Paggiaro (Pisa, Italy)
| |
Caspase-1 pathway in COPD
P. Sobradillo, R. Faner, A. Agustí, E. Ballester, N. Soler, J. Yagüe, M. Juan, J. I. Aróstegui (Barcelona, Spain)
| |
Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency
H. Stone, E. Sapey, R. Stockley (Birmingham, United Kingdom)
| |
Differential involvement of IκB kinases α and β in asthma and COPD
R. Gagliardo, P. Chanez, M. Profita, G. D. Albano, A. M. Montalbano, F. Pompeo, A. Bonanno, A. M. Merendino, M. Gjomarkaj (Palermo, Italy; Marseille, France)
| |